Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Decibel Therapeutics Inc. is currently overseeing 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct art units, reflecting a variety of specialized focuses within the biotech sector. The prosecution involves 7 distinct examiners, which is equal to the total number of pending actions.
The busiest examiner, RAHMAN, MASUDUR, is currently handling 1 pending action. This indicates that every one of the 7 pending office actions is being reviewed by a different individual. For a company in the Biotechnology & Pharmaceuticals space, this distribution across 7 distinct examiners and 4 distinct art units means that prosecution strategies must be customized for each specific case. Practitioners should be prepared to navigate these different environments while addressing the specific concerns of RAHMAN, MASUDUR and the other examiners currently reviewing the company's intellectual property.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Double-patenting only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMAN, MASUDUR | 1 | 72.7% | +31.7% |
| LARA, CAROLINE MONSERRAT | 1 | 100.0% | +0.0% |
| O'NEILL, MARISOL ANN | 1 | 53.1% | +68.2% |
| POPA, ILEANA | 1 | 21.4% | +15.1% |
| SINGH, ANOOP KUMAR | 1 | 43.0% | +67.6% |
| TRAN, CHRISTINA L | 1 | 51.6% | +48.2% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18626156 | MODIFIED REP-CAP PLASMIDS AND USES THEREOF | LARA, CAROLINE MONSERRAT | — |
| 18289028 | COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS | POPA, ILEANA | — |
| 17924578 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATION | SINGH, ANOOP KUMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17413223 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE | REYNOLDS, FRED H | 28d |
| 17794673 | METHODS AND COMPOSITIONS FOR GENERATING TYPE 1 VESTIBULAR HAIR CELLS | TRAN, CHRISTINA L | 62d |
| 19027519 | MYOSIN 15 PROMOTERS AND USES THEREOF | RAHMAN, MASUDUR | — |
| 18444107 | METHODS AND COMPOSITIONS FOR ADMINISTERING OTOFERLIN DUAL VECTOR SYSTEMS | O'NEILL, MARISOL ANN | — |
| 18289028 | COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS | POPA, ILEANA | — |
| 17924578 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATION | SINGH, ANOOP KUMAR | — |
| Art Unit | Apps |
|---|---|
| 1633 | 4 |
| 1632 | 1 |
| 1637 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19027519 | MYOSIN 15 PROMOTERS AND USES THEREOF | RAHMAN, MASUDUR | 1633 | DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18626156 | MODIFIED REP-CAP PLASMIDS AND USES THEREOF | LARA, CAROLINE MONSERRAT | 1633 | §102§103§112 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18444107 | METHODS AND COMPOSITIONS FOR ADMINISTERING OTOFERLIN DUAL VECTOR SYSTEMS | O'NEILL, MARISOL ANN | 1633 | §103DP | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18289028 | COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS | POPA, ILEANA | 1633 | §103§112 | Non-Final OA | — | Pending | Oct 31, 2023 |
| 17924578 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATION | SINGH, ANOOP KUMAR | 1632 | §102§103§112 | Final Rejection | — | Pending | Nov 10, 2022 |
| 17794673 | METHODS AND COMPOSITIONS FOR GENERATING TYPE 1 VESTIBULAR HAIR CELLS | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | 62d | Pending | Jul 22, 2022 |
| 17413223 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 28d | Pending | Jun 11, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial